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There is increasing recognition of the important role of 
skeletal muscle for health and disease. This is exemplified 
by a growing awareness of the clinical importance of 
sarcopenia1 - ‘a progressive and generalised skeletal muscle 
disorder that involves the accelerated loss of muscle mass 
and function’2 – which in the last 5 years has been assigned 
an ICD-10 code3. 
Despite progress, there remain well-documented 
challenges for clinical practice and research on sarcopenia1,2. 
One of the most important is the ongoing debate relating 
to how sarcopenia should be operationally defined1. Of a 
number of consensus definitions proposed over the last 
decade, the European Working Group on Sarcopenia in Older 
People’s (EWGSOP) definition has gained considerable 
traction4. It was therefore noteworthy when an extended 
working group, EWGSOP-2, published a revised definition 
in 2019 to reflect updates to relevant evidence5. 
In working towards the aim of a true consensus definition 
and improved understanding of sarcopenia, each time a new 
definition is proposed it is important to compare this with 
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existing definitions6-9. Work has thus been undertaken to 
compare the EWGSOP-2 definition with the EWGSOP and 
other definitions10-14. These comparisons have highlighted 
that prevalence estimates vary markedly and often have 
limited overlap i.e. identify different groups of people within a 
population as sarcopenic. This is a well-recognised challenge; 
a systematic review in 2019 reported that estimates of 
sarcopenia prevalence varied between 9.9 and 40.4% 
depending on the definition used and emphasised the lack of 
agreement between definitions9. 
The differences that these comparison studies highlight 
have important implications that need to be resolved. 
However, alongside these differences, it is also important to 
consider the impact of variation in how the core measures 
on which any one definition is based are assessed; this has 
been given considerably less attention. Identification of low 
muscle strength is an important step in the case-finding of 
sarcopenia as defined by EWGSOP2 and other groups. The 
EWGSOP2 propose doing this via assessment of handgrip 
strength or chair rises5. A number of sources of variation in 
the protocols commonly used to assess grip strength have 
been documented15-18 one of which is the type of hand-held 
dynamometer used. Some studies have shown variation in 
the grip strength achieved by individuals when tested using 
different makes and model of hand-held dynamometer19-22. 
However, only one study, of community dwelling Japanese 
adults aged 69-89 years, has considered the implications 
of this for the case-finding of low muscle strength. In this 
comparison of two types of hand-held dynamometer (Jamar 
hydraulic and Smedley), there was marked variation in the 
prevalence of weakness identified22.
In another recent cross-over study, measurements of 
maximum grip strength achieved by the same community-
dwelling individuals assessed in a random order using 
four different makes and model of commonly used hand-
held dynamometer, including electronic devices not 
previously examined were compared. Mean differences in 
maximum grip strength of between 4 and 5 kg were found 
when comparing hydraulic or spring-gauge devices with 
electronic devices23. In this report, we aimed to assess 
the impact of these measurement differences on the case-
finding of low muscle strength to help inform future work 
on sarcopenia definitions.
We utilise data from a randomised, repeated 
measurements cross-over study, full details described 
elsewhere23. In summary, participants were 118 men and 
women, aged 45 to 74 years, who had previously taken 
part in a market research study, resided in London or the 
South East of England and who agreed, on invitation after 
checks to ensure their eligibility, to participate in a trial 
to compare different devices commonly used to measure 
grip strength, blood pressure and lung function. This 
study received ethical approval from the local UCL ethics 
committee (ref: 6338/001) and all participants gave 
written informed consent.
During attendance at a research office in London between 
October 2015 and January 2016, study participants 
completed a 2-page questionnaire on sociodemographics 
and health status. This included questions on whether 
they had arthritis or other musculoskeletal conditions that 
affect their hands and have difficulty because of long-term 
health problems holding something heavy like a full kettle 
or removing a stiff lid from a jar. They then had their grip 
strength, blood pressure and lung function assessed by a 
trained researcher. 
Grip strength was assessed using four types of hand-
held dynamometer in a randomly allocated order, with 5-10 
minutes between each set of grip strength measurements 
to prevent participant fatigue. These devices were those 
most commonly used in UK longitudinal studies: Jamar 
Hydraulic; Jamar Plus+ Digital; Nottingham Electronic; 
Smedley. The same standardised protocol15,23 was used 
for each set of measurements (see Appendix 1). After 
each test, the strength (kg) achieved was recorded. 
For each device, two measurements were assessed 
in each hand. The use of a standardised protocol and 
assessments in both hands ensured that any variations in 
grip strength measurements observed could be attributed 
to dynamometer type and not to other factors (such as 
handedness or position during testing).
After identifying the maximum grip strength achieved 
(from all four measures, two in each hand) by each individual 
using each device we applied the EWGSOP25 recommended 
cut-points for low muscle strength of <16 kg for women and 
<27 kg for men. We then summarised the prevalence of low 
muscle strength for each device and assessed the agreement 
between pairs of devices using kappa statistics. 
Among the 118 community-dwelling men and women 
who participated in this study, 20 (17%) reported arthritis 
or another musculoskeletal condition that affects their hands 
and 24 (20%) reported some or a lot of difficulty holding 
something heavy. Prevalence estimates of low muscle 
strength varied by dynamometer type with a range of 3% to 
22% for men and 3% to 15% for women (Table 1).
Of the 13 men identified as having low muscle strength by 
at least one of the four dynamometers, only one participant 
was identified by all four dynamometers and seven by just 
one device (and in all cases this was the same device) (Table 
2 and Appendix Supplementary Figure 1). When comparing 
pairs of devices, kappa statistics ranged from 0.22 to 
0.55 suggesting poor to moderate agreement. Agreement 
between devices among women was lower with kappa 
statistics ranging from 0.13 to 0.46; of the 15 women 
classified as having low muscle strength by at least one of 
the four dynamometers, only one was identified by all four 
and ten by only one. 
In a study comparing four commonly used hand-held 
dynamometers, we have shown that identification of low 
muscle strength is influenced by the type of dynamometer 
used to assess grip strength. The differences in prevalence 
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estimates and the limited overlap in case-finding between 
devices that we have identified are likely to have important 
implications for research and clinical practice that need to be 
carefully considered in future work on sarcopenia.
Our findings concur with those from a previous study 
of older Japanese adults which compared two of the four 
devices we assessed22. As we were unable to compare the 
strength of associations between low muscle strength, 
identified by each of the four devices, and important health 
outcomes due to limited statistical power and no longitudinal 
assessment of relevant health outcomes, further research 
is required to clarify the implications of our findings. As 
our study population were aged 45 to 74 years, additional 
research is also required to establish whether these results 
are generalizable to older populations where sarcopenia is 
more prevalent. 
It has previously been argued that differences in the 
absolute measures of grip strength recorded when using 
different makes and models of hand-held dynamometers may 
not be a major concern when pooling grip strength data for use 
in epidemiological studies of association on the assumption 
that different devices rank people equivalently24,25. However, 
these new findings highlight that when applying absolute cut-
points to grip strength measures, systematic measurement 
differences between different types of dynamometer are a 
cause for concern. This suggests that there may be benefits 
of avoiding the application of cut-points and instead using 
continuous measures in research whenever possible. 
The application of cut-points is necessary for case-finding 
in clinical practice and so cannot always be avoided. Research 
is ongoing to validate cut-points for grip strength and other 
measures required for sarcopenia case-finding. Our findings 
suggest that more work is also required to understand how 
best to standardise the measurement of each of the different 
components of any one sarcopenia definition to which these 
cut-points are applied. For low muscle strength, it is important 
to recognise that there are a number of potential sources of 
variation in the measurement of grip strength that may have 
an impact on case-finding15,17,26-28. While excellent work has 
been done to highlight some of these factors and promote 
the standardisation of assessments15, it may be unrealistic 
to expect that all research and clinical facilities will ever have 
access to exactly the same measurement devices and be 
able to follow precisely the same protocols. In recognition 
of this, options to consider include the development of 
correction factors that can be applied to take account of 
measurement differences between devices. Alternatively, it 
may be necessary to consider developing different reference 
values and cut-points for different types of measurement 
device. However, whether this is feasible remains to be seen, 
especially as it can be expected that existing measurement 
devices will be updated and new devices will continue to be 
developed and introduced. Creating standard protocols that 
are followed to validate initial results prior to a diagnosis 
being confirmed and interventions being implemented, 
Men (N=59) Women (N=59)
Age (y) – mean (SD) 59.3 (7.7) 59.9 (8.4)
Low muscle strength* – n (%)
Jamar Hydraulic 5 (8.5) 9 (15.3)
Jamar Plus+ Digital 2 (3.4) 3 (5.1)
Nottingham Electronic 2 (3.4) 9 (15.3)
Smedley 13 (22.0) 2 (3.4)
Maximum grip strength (kg) – mean (SD)
Jamar Hydraulic 35.2 (8.5) 20.5 (5.7)
Jamar Plus+ Digital 39.4 (8.5) 25.2 (5.3)
Nottingham Electronic 40.9 (10.3) 24.4 (6.9)
Smedley 32.4 (7.4) 22.9 (5.0)
* Low muscle strength defined as maximum grip strength <27 kg for men and <16 kg for women5.
Table 1. Prevalence of low muscle strength and mean maximum grip strength (kg) by dynamometer type.













At least 1 dynamometer 13 15
Table 2. Number of men and women classified as low muscle strength 
by number of dynamometers.
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similar to those followed in diagnosing hypertension could 
also have value29. This could involve taking initial grip 
strength measurements using whatever device is available 
and, where low muscle strength is indicated undertaking 
additional assessments of muscle strength using a gold-
standard method. 
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APPENDIX 1 
Grip strength measurement protocol
Four different types of dynamometer will be used during 
the calibration study: the Nottingham electronic; Jamar 
hydraulic; Jamar digital; Smedley. Wherever possible, four 
measures will be ascertained using each device (2 measures 
in each hand (in the order: Left 1, Right 1, Left 2, Right 2)).
To ensure comparability of measures across devices a 
standard protocol will be used when performing each set 
of grip strength tests (see Roberts et al, Age and Ageing 




•  A standard straight backed chair with solid arms
Checks before performing the first set of grip strength 
measurements:
Exclusion criteria.
•  swelling or inflammation, severe pain or recent injury in 
their hands
•  surgery to the hand in the last 6 months (if there is a 
problem with one hand only use just take measurements 
on the other hand)
•  blood pressure over ≥200 mmHg for systolic or ≥120 
mmHg for diastolic.
If the participant has any of these, explain to the participant 




“We would like to assess the strength of your hand 
in a gripping action. This test will be done using 4 
different machines and each time I would like to take 2 
measurements in each hand.”
NOTE: The participant should have use of both hands as a 
screening question will have been asked before recruitment. 
However, if the participant only has use of one hand please 
record this and perform the two measurements in that hand.
READ OUT:
“Which is your dominant hand?“
Proceed with the tests (if participant has use of both hands 
the order of the tests for each device will be: Left hand, Right 
hand, Left hand, Right hand)
GENERAL PROTOCOL:
1.     Sit the participant comfortably in a standard chair with 
legs, back support and fixed arms. Use the same chair 
for every measurement.
2.     Ask the participant to rest their left forearm on the 
arm of the chair in the mid-prone position (i.e. with the 
thumb facing upwards) and their wrist just over the end 
of the arm of the chair in a neutral but slightly extended 
position.
3.     Place the dynamometer handle in their left hand (and 
when using either of the Jamar devices carefully place 
the wrist strap around the participant’s left wrist)
4.     Position the hand so that the thumb is round one side 
of the handle and the four fingers are around the other 
side. The instrument should feel comfortable in the 
hand. Alter the position of the handle if necessary. Large 
rings may need to be removed.
5.     Tell the participant that after I say ‘And Go’ I will need 
you to squeeze the handle of the device as hard as you 
can, just for a couple of seconds until I tell you to stop 
and then let go. Make it clear that gripping very tightly 
registers the best score.
6.     Once you are happy that the participant’s arm is 
positioned correctly and that the device is ready to 
record you are then ready to take the measure.
7.     Say ‘And Go!’ at which point the participant should 
squeeze as hard as they can for a couple of seconds 
and then release quickly. You should provide verbal 
encouragement by telling the participant to ‘Squeeze, 
squeeze, squeeze’ and then you should tell them after a 
few seconds to stop.
8.     During the test please make sure that the participant’s 
arm remains in position resting on the arm of the chair.
9.     Record the value on the display to the nearest 0.1kg (for 
the Jamar digital and Nottingham Electronic devices), 
1kg (for the Jamar hydraulic device) or 0.5kg (for the 
Smedley device).
10.  Once the value for the left hand is recorded carefully take 
the dynamometer from the participant and repeat the 
test in the participant’s right hand.
NOW REPEAT THE INSTRUCTIONS ABOVE AND TAKE A 
SECOND MEASUREMENT IN THE LEFT HAND, FOLLOWED 
BY A SECOND MEASUREMENT IN THE RIGHT HAND
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Appendix Supplementary Figure 1. Overlap between men and women classified as low muscle strength by four different hand-held dynamometers 
(Jamar Hydraulic (Jamar H); Jamar Plus+ Digital (Jamar D); Nottingham Electronic; Smedley).
